Evaluation of the in vitro and in vivo proinflammatory activities of gold (+) and gold (−) nanoparticles

Inflammation Research

Volumn 66, Issue 11, 2017, Pages 981-992

  Durocher, Isabelle ^a   Noël, Claudie ^a   Lavastre, Valérie ^a   Girard, Denis ^a  

^a UNIVERSITÉ LAVAL   (Canada)

Author keywords

Chemokines; Cytokines; Inflammation; Nanoparticles; Neutrophils

Indexed keywords

COLONY STIMULATING FACTOR 1; CXCL1 CHEMOKINE; GAMMA INTERFERON INDUCIBLE PROTEIN 10; GELATINASE; GELATINASE B; GOLD; GOLD NANOPARTICLE; INTERLEUKIN 12P70; INTERLEUKIN 16; INTERLEUKIN 17; INTERLEUKIN 1ALPHA; INTERLEUKIN 2; INTERLEUKIN 23; INTERLEUKIN 27; INTERLEUKIN 3; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; INTERLEUKIN 8; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; RANTES; STROMAL CELL DERIVED FACTOR 1; TISSUE INHIBITOR OF METALLOPROTEINASE 1; CYTOKINE; LIPOPOLYSACCHARIDE; METAL NANOPARTICLE;

AIR POUCH; ANIMAL EXPERIMENT; ANTIINFLAMMATORY ACTIVITY; APOPTOSIS; ARTICLE; CELL ACTIVATION; CELL MIGRATION; CHEMOTAXIS; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; EXTRACELLULAR SPACE; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NERVOUS SYSTEM INFLAMMATION; NEUTROPHIL; NONHUMAN; PARTICLE SIZE; SCANNING ELECTRON MICROSCOPY; SURFACE CHARGE; TRANSMISSION ELECTRON MICROSCOPY; ZETA POTENTIAL; ZYMOGRAPHY; ANIMAL; CELL CULTURE; CELL SURVIVAL; DRUG EFFECT; FEMALE; IMMUNOLOGY; METABOLISM; PHYSIOLOGY; ULTRASTRUCTURE;

ANIMALS; APOPTOSIS; CELL SURVIVAL; CELLS, CULTURED; CHEMOTAXIS; CYTOKINES; FEMALE; GELATINASES; GOLD; HUMANS; LIPOPOLYSACCHARIDES; METAL NANOPARTICLES; MICE; MICROSCOPY, ELECTRON, TRANSMISSION; NEUTROPHILS;

EID: 85021829898     PISSN: 10233830     EISSN: 1420908X     Source Type: Journal    
DOI: 10.1007/s00011-017-1078-7     Document Type: Article

References (37)

1. Almeida JP, Figueroa ER, Drezek RA. Gold nanoparticle mediated cancer immunotherapy. Nanomedicine. 2014;10:503–14.
2. Coelho SC, Rocha S, Juzenas P, Sampaio P, Almeida GM, Silva FS, et al. Gold nanoparticle delivery-enhanced proteasome inhibitor effect in adenocarcinoma cells. Expert Opin Drug Deliv. 2013;10:1345–52.
3. Chandolu V, Dass CR. Treatment of lung cancer using nanoparticle drug delivery systems. Curr Drug Discov Technol. 2013;10:170–6.
4. Tarasova NK, Gallud A, Ytterberg AJ, Chernobrovkin A, Aranzaes JR, Astruc D, et al. Cytotoxic and proinflammatory effects of metal-based nanoparticles on THP-1 monocytes characterized by combined proteomics approaches. J Proteome Res. 2017;16:689–97.
5. Choi SY, Jeong S, Jang SH, Park J, Park JH, Ock KS, et al. In vitro toxicity of serum protein-adsorbed citrate-reduced gold nanoparticles in human lung adenocarcinoma cells. Toxicol In Vitro. 2012;26:229–37.
6. Choi K, Riviere JE, Monteiro-Riviere NA. Protein corona modulation of hepatocyte uptake and molecular mechanisms of gold nanoparticle toxicity. Nanotoxicology. 2017;11:64–75.
7. Hussain S, Vanoirbeek JA, Luyts K, De Vooght V, Verbeken E, Thomassen LC, et al. Lung exposure to nanoparticles modulates an asthmatic response in a mouse model. Eur Respir J. 2011;37:299–309.
8. Deng ZJ, Liang M, Monteiro M, Toth I, Minchin RF. Nanoparticle-induced unfolding of fibrinogen promotes Mac-1 receptor activation and inflammation. Nat Nanotechnol. 2011;6:39–44.
9. Cho WS, Cho M, Jeong J, Choi M, Cho HY, Han BS, et al. Acute toxicity and pharmacokinetics of 13 nm-sized PEG-coated gold nanoparticles. Toxicol Appl Pharmacol. 2009;236:16–24.
10. Sumbayev VV, Yasinska IM, Garcia CP, Gilliland D, Lall GS, Gibbs BF, et al. Gold nanoparticles downregulate interleukin-1beta-induced pro-inflammatory responses. Small. 2013;9:472–7.
11. Tsai CY, Shiau AL, Chen SY, Chen YH, Cheng PC, Chang MY, et al. Amelioration of collagen-induced arthritis in rats by nanogold. Arthritis Rheum. 2007;56:544–54.
12. Labens R, Lascelles BD, Charlton AN, Ferrero NR, Van Wettere AJ, Xia XR, et al. Ex vivo effect of gold nanoparticles on porcine synovial membrane. Tissue Barriers. 2013;1:e24314.
13. Zhang XD, Wu D, Shen X, Liu PX, Yang N, Zhao B, et al. Size-dependent in vivo toxicity of PEG-coated gold nanoparticles. Int J Nanomed. 2011;6:2071–81.
14. Noel C, Simard JC, Girard D. Gold nanoparticles induce apoptosis, endoplasmic reticulum stress events and cleavage of cytoskeletal proteins in human neutrophils. Toxicol In Vitro. 2016;31:12–22.
15. Bartneck M, Keul HA, Singh S, Czaja K, Bornemann J, Bockstaller M, et al. Rapid uptake of gold nanorods by primary human blood phagocytes and immunomodulatory effects of surface chemistry. ACS Nano. 2010;4:3073–86.
16. Della Coletta AM, Bachiega TF, de Quaglia e Silva JC, Soares AM, De Faveri J, Marques SA, et al. Neutrophil extracellular traps identification in tegumentary lesions of patients with paracoccidioidomycosis and different patterns of NETs generation in vitro. PLoS Negl Trop Dis. 2015;9:e0004037.
17. Bartneck M, Keul HA, Zwadlo-Klarwasser G, Groll J. Phagocytosis independent extracellular nanoparticle clearance by human immune cells. Nano Lett. 2010;10:59–63.
18. Poirier M, Simard JC, Antoine F, Girard D. Interaction between silver nanoparticles of 20 nm (AgNP20) and human neutrophils: induction of apoptosis and inhibition of de novo protein synthesis by AgNP20 aggregates. J Appl Toxicol. 2014;34:404–12.
19. 2 and ZnO nanoparticles and modulation of the degranulation process in human neutrophils. Toxicol Lett. 2013;221:57–63.
20. Simard JC, Simon MM, Tessier PA, Girard D. Damage-associated molecular pattern S100A9 increases bactericidal activity of human neutrophils by enhancing phagocytosis. J Immunol. 2011;186:3622–31.
21. Arora S, Jain J, Rajwade JM, Paknikar KM. Interactions of silver nanoparticles with primary mouse fibroblasts and liver cells. Toxicol Appl Pharmacol. 2009;236:310–8.
22. Rosas-Hernandez H, Jimenez-Badillo S, Martinez-Cuevas PP, Gracia-Espino E, Terrones H, Terrones M, et al. Effects of 45-nm silver nanoparticles on coronary endothelial cells and isolated rat aortic rings. Toxicol Lett. 2009;191:305–13.
23. Durocher I, Girard D. In vivo proinflammatory activity of generations 0-3 (G0-G3) polyamidoamine (PAMAM) nanoparticles. Inflamm Res. 2016;65:745–55.
24. Goncalves DM, Girard D. Evidence that polyhydroxylated C60 fullerenes (fullerenols) amplify the effect of lipopolysaccharides to induce rapid leukocyte infiltration in vivo. Chem Res Toxicol. 2013;26:1884–92.
25. Goncalves DM, Girard D. Zinc oxide nanoparticles delay human neutrophil apoptosis by a de novo protein synthesis-dependent and reactive oxygen species-independent mechanism. Toxicol In Vitro. 2014;28:926–31.
26. Savoie A, Lavastre V, Pelletier M, Hajto T, Hostanska K, Girard D. Activation of human neutrophils by the plant lectin Viscum album agglutinin-I: modulation of de novo protein synthesis and evidence that caspases are involved in induction of apoptosis. J Leukoc Biol. 2000;68:845–53.
27. Ratthe C, Pelletier M, Roberge CJ, Girard D. Activation of human neutrophils by the pollutant sodium sulfite: effect on cytokine production, chemotaxis, and cell surface expression of cell adhesion molecules. Clin Immunol. 2002;105:169–75.
28. Goncalves DM, Girard D. Titanium dioxide (TiO(2)) nanoparticles induce neutrophil influx and local production of several pro-inflammatory mediators in vivo. Int Immunopharmacol. 2011;21:21.
29. Ratthe C, Ennaciri J, Garces Goncalves DM, Chiasson S, Girard D. Interleukin (IL)-4 induces leukocyte infiltration in vivo by an indirect mechanism. Mediat Inflamm. 2009;2009:193970.
30. Dransfield I, Buckle AM, Savill JS, McDowall A, Haslett C, Hogg N. Neutrophil apoptosis is associated with a reduction in CD16 (Fc gamma RIII) expression. J Immunol. 1994;153:1254–63.
31. Liz R, Simard JC, Leonardi LB, Girard D. Silver nanoparticles rapidly induce atypical human neutrophil cell death by a process involving inflammatory caspases and reactive oxygen species and induce neutrophil extracellular traps release upon cell adhesion. Int Immunopharmacol. 2015;28:616–25.
32. Moisan E, Girard D. Cell surface expression of intermediate filament proteins vimentin and lamin B1 in human neutrophil spontaneous apoptosis. J Leukoc Biol. 2006;79:489–98.
33. Pelletier M, Bouchard A, Girard D. In vivo and in vitro roles of IL-21 in inflammation. J Immunol. 2004;173:7521–30.
34. Li Y, Italiani P, Casals E, Valkenborg D, Mertens I, Baggerman G, et al. Assessing the immunosafety of engineered nanoparticles with a novel in vitro model based on human primary monocytes. ACS Appl Mater Interfaces. 2016;8(42):28437–28447
35. Bancos S, Stevens DL, Tyner KM. Effect of silica and gold nanoparticles on macrophage proliferation, activation markers, cytokine production, and phagocytosis in vitro. Int J Nanomed. 2015;10:183–206.
36. Vandooren J, Berghmans N, Dillen C, Van Aelst I, Ronsse I, Israel LL, et al. Intradermal air pouch leukocytosis as an in vivo test for nanoparticles. Int J Nanomed. 2013;8:4745–56.
37. Girard D. Using the air pouch model for assessing in vivo inflammatory activity of nanoparticles. Int J Nanomed. 2014;9:1105–7.